^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Immuncell-LC (GCC4002)

    i
    Other names: GCC4002, Inno-LC-01
    Associations

    News

    Trials
    Company:
    GC Biopharma, Rivaara Immune
    Drug class:
    T-cell stimulant
    Related drugs:
    Associations

    News

    Trials
    1m
    Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea (clinicaltrials.gov)
    P=N/A, N=230, Not yet recruiting, GC Cell Corporation
    New trial
    |
    Immuncell-LC (GCC4002)
    over1year
    Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation (clinicaltrials.gov)
    P1/2, N=19, Completed, GC Cell Corporation | Recruiting --> Completed | Trial completion date: Mar 2023 --> Aug 2022
    Trial completion • Trial completion date • Immune cell
    |
    Immuncell-LC (GCC4002)
    over1year
    Safety and Efficacy of "Immuncell-LC" in TACE Therapy (clinicaltrials.gov)
    P2, N=76, Completed, GC Cell Corporation | Active, not recruiting --> Completed
    Trial completion • Immune cell
    |
    Immuncell-LC (GCC4002)